First-of-its-kind service empowers discreet and more convenient access to testing and treatment for vaginitis and similar genital tract infections such as chlamydia, gonorrhea, trichomoniasis and ...
Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to ...
SECAUCUS, N.J., Nov. 9, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced the launch of Quest Mobile™, which makes ...
Quest Diagnostics, a leader in diagnostic information services, announced the availability of a new service aimed at increasing convenience and speed of testing and treatment of several common genital ...
(RTTNews) - Quest Diagnostics (DGX), a diagnostic services provider, announced Wednesday a new FDA-cleared human papillomavirus (HPV) self-collection solution aimed at broadening access to HPV ...
Quest Diagnostics (NYSE: DGX ), a leader in diagnostic information services, today announced the availability of a new service aimed at increasing convenience and speed of testing and treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results